Asset Details
Do you wish to reserve the book?
Beyond prion‐like spreading in neurodegenerative disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Beyond prion‐like spreading in neurodegenerative disease
Do you wish to request the book?
Beyond prion‐like spreading in neurodegenerative disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Beyond prion‐like spreading in neurodegenerative disease
2025
Overview
To design effective therapies for neurodegenerative diseases, it is critical to understand the processes that trigger protein aggregation in sequential brain regions as the disease progresses. Aggregates formed in many neurodegenerative diseases, including Alzheimer's and Parkinson's disease, are capable of seeding, leading to the proposal to regard them all as prion‐like. We here argue that the utility of this classification is limited; the terms protein misfolding and aggregation‐related diseases describe the general class of diseases, and the connotation of prion‐like that the spreading of infectious prions is the rate‐limiting process narrows the view of possible mechanisms. Instead, we suggest four factors along which to compare different diseases and model systems, providing a clearer basis to consider the different ways in which pathology can spread, account for factors beyond the aggregating protein, such as declining protein homeostasis with age, and understand the differences between model systems and human disease. Highlights Four aspects by which to classify neurodegenerative diseases are proposed. Aggregates in health and inflammation are important factors. Prion‐like spreading classification is not sufficient to capture the necessary nuance. Different diseases and model systems are dominated by different aspects.
